Vered Raz-Avayo - 18 Mar 2026 Form 3 Insider Report for Foresight Autonomous Holdings Ltd. (FRSX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
30 Mar 2026, 09:13:01 UTC
Prior SEC filing
16 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Vered Raz-Avayo

Key filing fact

Vered Raz-Avayo filed Form 3 for Foresight Autonomous Holdings Ltd. (FRSX) on 30 Mar 2026.

Key facts

  • This page summarizes Vered Raz-Avayo's Form 3 filing for Foresight Autonomous Holdings Ltd. (FRSX).
  • 0 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 30 Mar 2026, 09:13.

Change

  • Previous filing in this sequence was filed on 16 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001795316 Primary reporting owner

Raz-Avayo Vered

Relationship
Director
Address
C/O FORESIGHT AUTONOMOUS, 7 GOLDA MEIR ISRAEL, NESS ZIONA, ISRAEL
Signature
/s/ Vered Raz-Avayo
Signature date
30 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FRSX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
150,000
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FRSX holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
42,857
Exercise price
$1.12
Footnotes
F2, F3, F4
FRSX holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
21,429
Exercise price
$1.12
Footnotes
F5, F6
FRSX holding Derivative

Stock Options (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
57,143
Exercise price
$1.12
Footnotes
F7, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Includes 75,000 ordinary shares, no par value per share, of the Issuer (the "Ordinary Shares") issuable upon the vesting of restricted share units ("RSUs") through July 1, 2027. Each RSU represents the right to receive one Ordinary Share.

Footnote F2

The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.

Footnote F3

The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

Footnote F4

The options were granted on August 27,2017 and fully vested as of July 16, 2020.

Footnote F5

The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

Footnote F6

The options were granted on September 23 ,2019 and fully vested as of July 31, 2022.

Footnote F7

The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

Footnote F8

The options were granted on October 20 ,2022 and fully vested as of September 30,2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .